Press release
Global mRNA Synthesis and Manufacturing Market to grow at a CAGR of 4.32% by 2032, Evaluates DelveInsight | Thermo Fisher Scientific Inc., New England Biolabs, TriLink BioTechnologies, DH Life Sciences, LLC., F. Hoffmann-La Roche Ltd., Telesis Bio Inc
DelveInsight's "mRNA Synthesis and Manufacturing Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key mRNA Synthesis and Manufacturing companies actively working in the market.
To know more about why North America is leading the market growth in the mRNA Synthesis and Manufacturing market, get a snapshot of the report mRNA Synthesis and Manufacturing Market Trends
https://www.delveinsight.com/sample-request/mrna-synthesis-and-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
mRNA Synthesis and Manufacturing Overview
mRNA synthesis and manufacturing involve the production of messenger RNA (mRNA) molecules, which serve as the basis for mRNA-based therapies and vaccines. The process typically includes DNA template preparation, in vitro transcription (IVT) to generate mRNA, capping, polyadenylation, purification, and formulation. Manufacturing is performed under sterile, Good Manufacturing Practice (GMP) conditions to ensure safety and efficacy. mRNA manufacturing enables the rapid development of vaccines (e.g., COVID-19 vaccines), cancer immunotherapies, and treatments for genetic diseases. Scalable production, quality control, and delivery technologies like lipid nanoparticles (LNPs) are key components of the process.
DelveInsight Analysis: The global market size for mRNA synthesis and manufacturing is projected to expand at a compound annual growth rate (CAGR) of 4.32% between 2025 and 2032.
mRNA Synthesis and Manufacturing Market Insights
Geographically, In 2024, North America is projected to hold the largest share of the global mRNA synthesis and manufacturing market. The region hosts a strong network of leading biotech and pharmaceutical companies, including Moderna and Pfizer, key players in advancing mRNA vaccine development and manufacturing. North America's advantage is further supported by advanced research infrastructure, favorable regulatory frameworks like the FDA's fast-track approvals, and rising demand for mRNA-based therapies targeting cancer immunotherapy and infectious diseases. Additionally, increased investments in manufacturing capabilities and strategic industry collaborations continue to drive innovation and strengthen North America's leadership in the mRNA sector.
To read more about the latest highlights related to mRNA Synthesis and Manufacturing, get a snapshot of the key highlights entailed in the mRNA Synthesis and Manufacturing
https://www.delveinsight.com/report-store/mrna-synthesis-and-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the mRNA Synthesis and Manufacturing Market Report
• In August 2024, The U.S. Food and Drug Administration (FDA) has approved and issued emergency use authorization (EUA) for the updated mRNA COVID-19 vaccine (2024-2025 formulation), which now includes a monovalent component targeting the Omicron variant KP.2 strain of SARS-CoV-2.
• In April 2024, TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company and global supplier of life science reagents and services, announced the official launch of its new cGMP-compliant mRNA manufacturing facility.
• In September 2023, PackGene Biotech and Kudo Biotechnology formed a partnership to provide tailored mRNA manufacturing services.
• In August 2022, New England Biolabs® launched the Faustovirus Capping Enzyme, an innovative enzymatic solution designed for mRNA capping in the mRNA manufacturing process.
• Thus, owing to such developments in the market, rapid growth will be observed in the mRNA Synthesis and Manufacturing market during the forecast period
Key Players in the mRNA Synthesis and Manufacturing Market
Some of the key market players operating in the mRNA Synthesis and Manufacturing market include- Thermo Fisher Scientific Inc., New England Biolabs, TriLink BioTechnologies, DH Life Sciences, LLC., F. Hoffmann-La Roche Ltd., Telesis Bio Inc., Promega Corporation, Jena Bioscience, GenScript, RiboPro, Takara Bio, Lonza, Sigma-Aldrich, Agilent Technologies, Integrated DNA Technologies, Inc., and others.
Which MedTech key players in the mRNA Synthesis and Manufacturing market are set to emerge as the trendsetter explore @ Key mRNA Synthesis and Manufacturing Companies
https://www.delveinsight.com/sample-request/mrna-synthesis-and-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the mRNA Synthesis and Manufacturing Market Landscape
Moreover, the growing demand for mRNA vaccines and advancements in gene therapies are driving significant growth in the mRNA synthesis and manufacturing market. The success of mRNA-based COVID-19 vaccines has laid a strong foundation for the market's continued expansion. Companies are now enhancing their production capabilities to support both existing vaccines and new candidates targeting additional infectious diseases. For example, in August 2024, Pfizer and BioNTech shared progress on their mRNA-based combination vaccine targeting influenza and COVID-19 in adults aged 18-64. In a Phase 3 trial, the combination vaccine met one of its primary immunogenicity endpoints but did not achieve non-inferiority for the influenza B strain. However, it showed stronger responses to influenza A and comparable results for COVID-19. Additionally, Pfizer's Phase 2 study of its trivalent influenza mRNA vaccine demonstrated strong immune responses across all strains, outperforming a traditional flu vaccine.
Therefore, the factors outlined above are anticipated to drive the global growth of the mRNA synthesis and manufacturing market throughout the forecast period from 2025 to 2032.
Scope of the mRNA Synthesis and Manufacturing Market Report
• Coverage: Global
• Study Period: 2022-2032
• mRNA Synthesis and Manufacturing Market Segmentation By Product Type: Instruments and Reagents & Kits), Application (Research and Manufacturing)
• mRNA Synthesis and Manufacturing Market Segmentation By End Users: Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, and CROs & CDMOs
• mRNA Synthesis and Manufacturing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key mRNA Synthesis and Manufacturing Companies: Thermo Fisher Scientific Inc., New England Biolabs, TriLink BioTechnologies, DH Life Sciences, LLC., F. Hoffmann-La Roche Ltd., Telesis Bio Inc., Promega Corporation, Jena Bioscience, GenScript, RiboPro, Takara Bio, Lonza, Sigma-Aldrich, Agilent Technologies, Integrated DNA Technologies, Inc., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the mRNA Synthesis and Manufacturing market will grow by 2032? Click to get a snapshot of the mRNA Synthesis and Manufacturing Market Analysis
https://www.delveinsight.com/sample-request/mrna-synthesis-and-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 mRNA Synthesis and Manufacturing Market Report Introduction
2 mRNA Synthesis and Manufacturing Market Executive summary
3 Regulatory and Patent Analysis
4 mRNA Synthesis and Manufacturing Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on mRNA Synthesis and Manufacturing Market
7 mRNA Synthesis and Manufacturing Market Layout
8 Global Company Share Analysis - Key mRNA Synthesis and Manufacturing Companies
9 Company and Product Profiles
10 Project Approach
11 mRNA Synthesis and Manufacturing Market Drivers
12 mRNA Synthesis and Manufacturing Market Barriers
13 About DelveInsight
Latest Reports by DelveInsight
• Transcatheter Heart Valve Replacement Devices Market: https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market
• Bone Neoplasms Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market
• Peak Flow Meters Market: https://www.delveinsight.com/report-store/peak-flow-meters-market
• Neuroendoscopy Market: https://www.delveinsight.com/report-store/neuroendoscopy-market
• Nosocomial Infections Market: https://www.delveinsight.com/report-store/nosocomial-infections-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global mRNA Synthesis and Manufacturing Market to grow at a CAGR of 4.32% by 2032, Evaluates DelveInsight | Thermo Fisher Scientific Inc., New England Biolabs, TriLink BioTechnologies, DH Life Sciences, LLC., F. Hoffmann-La Roche Ltd., Telesis Bio Inc here
News-ID: 4096576 • Views: …
More Releases from DelveInsight Business Research
Anti-CD19 Antibody Pipeline 2025: Therapies Under Investigation, Clinical Trials …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Anti-CD19 Antibody pipeline constitutes 12+ key companies continuously working towards developing 12+ Anti-CD19 Antibody treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Anti-CD19 Antibody Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Anti-CD19 Antibody Market.
The Anti-CD19…
EGFR Non Small Cell Lung Cancer Pipeline 2025: MOA and ROA Insights, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, EGFR Non Small Cell Lung Cancer pipeline constitutes 25+ key companies continuously working towards developing 30+ EGFR Non Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The EGFR Non Small Cell Lung Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products…
Intrahepatic Cholangiocarcinoma Pipeline 2025: FDA Updates, Therapy Innovations, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Intrahepatic Cholangiocarcinoma pipeline constitutes 18+ key companies continuously working towards developing 20+ Intrahepatic Cholangiocarcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Intrahepatic Cholangiocarcinoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report…
Atopic Dermatitis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Ev …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 120+ Atopic Dermatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Atopic Dermatitis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
